Progressive Gastrointestinal Stromal Tumor
1 clinical trials · Condition
◉ Watch Progressive Gastrointestinal Stromal Tumor
| Record | Firm | Date |
|---|---|---|
| Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate (NCT00510354) | Novartis Pharmaceuticals | 2006-10-01 |
Track Progressive Gastrointestinal Stromal Tumor automatically
Every clearance here is in the API, with alerts when new ones post.